1. Home
  2. ULS vs BIO Comparison

ULS vs BIO Comparison

Compare ULS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UL Solutions Inc.

ULS

UL Solutions Inc.

N/A

Current Price

$66.91

Market Cap

15.6B

Sector

N/A

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$357.71

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ULS
BIO
Founded
1894
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.6B
10.1B
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
ULS
BIO
Price
$66.91
$357.71
Analyst Decision
Buy
Hold
Analyst Count
13
3
Target Price
$96.48
★ $328.33
AVG Volume (30 Days)
★ 698.1K
230.5K
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 0.88%
N/A
EPS Growth
N/A
★ 142.61
EPS
★ 1.66
N/A
Revenue
★ $3,053,000,000.00
$2,583,200,000.00
Revenue This Year
$5.25
N/A
Revenue Next Year
$7.23
$2.47
P/E Ratio
$38.39
★ N/A
Revenue Growth
★ 6.38
0.65
52 Week Low
$63.17
$236.73
52 Week High
$107.54
$396.23

Technical Indicators

Market Signals
Indicator
ULS
BIO
Relative Strength Index (RSI) 34.89 48.40
Support Level $63.17 $364.41
Resistance Level $73.62 $392.81
Average True Range (ATR) 1.92 9.33
MACD 0.38 -1.87
Stochastic Oscillator 32.36 33.74

Price Performance

Historical Comparison
ULS
BIO

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: